S. Allender, P. Scarborough, V. Peto, M. Rayner, L. Leal et al., European Cardiovascular Disease Statistics, 2008.

F. Rodríguez-artalejo, P. Guallar-castillón, V. Alvarez, F. Banegas, and J. , An??lisis cr??tico y propuestas de mejora de los sistemas de informaci??n sobre enfermedades cardiovasculares en Espa??a, Medicina Cl??nica, vol.131, issue.8, pp.302-311, 2008.
DOI : 10.1016/S0025-7753(08)72264-4

S. Allender, P. Scarborough, O. Flaherty, M. Capewell, and S. , Patterns of coronary heart disease mortality over the 20th century in England and Wales: Possible plateaus in the rate of decline, BMC Public Health, vol.80, issue.1, p.148, 2008.
DOI : 10.1136/hrt.80.1.40

L. Palmieri, K. Bennett, S. Giampaoli, and S. Capewell, Explaining the Decrease in Coronary Heart Disease Mortality in Italy Between, Am J Public Health, 1980.

L. Björck, A. Rosengren, K. Bennett, and G. Lappas, Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002, European Heart Journal, vol.30, issue.9, pp.1046-1056, 1986.
DOI : 10.1093/eurheartj/ehn554

S. Hardoon, P. Whincup, L. Lennon, S. Wannamethee, S. Capewell et al., How Much of the Recent Decline in the Incidence of Myocardial Infarction in British Men Can Be Explained by Changes in Cardiovascular Risk Factors?: Evidence From a Prospective Population-Based Study, Circulation, vol.117, issue.5, pp.598-604, 2008.
DOI : 10.1161/CIRCULATIONAHA.107.705947

D. Bhatt, P. Steg, E. Ohman, A. Hirsch, Y. Ikeda et al., International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis, JAMA, vol.295, issue.2, pp.180-189, 2006.
DOI : 10.1001/jama.295.2.180

K. Kotseva, D. Wood, D. Backer, G. , D. Bacquer et al., EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries, European Journal of Cardiovascular Prevention & Rehabilitation, vol.371, issue.1, pp.121-137, 2009.
DOI : 10.1097/HJR.0b013e3283294b1d

K. Kotseva, D. Wood, D. Backer, G. , D. Bacquer et al., Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries, The Lancet, vol.373, issue.9667, pp.929-940, 2009.
DOI : 10.1016/S0140-6736(09)60330-5

M. Wensing, S. Ludt, S. Campbell, J. Van-lieshout, E. Volbracht et al., European Practice Assessment of Cardiovascular risk management (EPA Cardio): protocol of an international observational study in primary care, Implementation Science, vol.23, issue.5, p.3, 2009.
DOI : 10.1093/fampra/cmi091

R. Conroy, K. Pyörälä, A. Fitzgerald, S. Sans, A. Menotti et al., Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project, European Heart Journal, vol.24, issue.11, pp.987-1003, 2003.
DOI : 10.1016/S0195-668X(03)00114-3

M. Cabana, C. Rand, N. Powe, A. Wu, M. Wilson et al., Why Don't Physicians Follow Clinical Practice Guidelines? A Framework for Improvement, Pediatric Research, vol.45, issue.4, Part 2 of 2, pp.1458-1465, 1999.
DOI : 10.1203/00006450-199904020-00719

F. Hobbs and L. Erhardt, Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey, Family Practice, vol.19, issue.6, pp.596-604, 2002.
DOI : 10.1093/fampra/19.6.596

I. Graham, M. Stewart, and M. Hertog, Factors impeding the implementation of cardiovascular prevention guidelines: findings from a survey conducted by the European Society of Cardiology, European Journal of Cardiovascular Prevention & Rehabilitation, vol.24, issue.5, pp.839-845, 2006.
DOI : 10.1097/01.hjr.0000219112.02544.24

L. Erhardt and F. Hobbs, A global survey of physicians??? perceptions on cholesterol management: the From The Heart study, International Journal of Clinical Practice, vol.12, issue.Suppl. 2, pp.1078-1085, 2007.
DOI : 10.1111/j.1742-1241.2007.01420.x

A. Celentano, S. Panico, V. Palmieri, B. Guillaro, C. Brancati et al., Citizens and family doctors facing awareness and management of traditional cardiovascular risk factors: Results from the Global Cardiovascular Risk Reduction Project (Help Your Heart Stay Young Study), Nutrition, Metabolism and Cardiovascular Diseases, vol.13, issue.4, pp.211-217, 2003.
DOI : 10.1016/S0939-4753(03)80013-3

L. Mosca, A. Linfante, E. Benjamin, K. Berra, S. Hayes et al., National Study of Physician Awareness and Adherence to Cardiovascular Disease Prevention Guidelines, Circulation, vol.111, issue.4, pp.499-510, 2005.
DOI : 10.1161/01.CIR.0000154568.43333.82

H. Doroodchi, M. Abdolrasulnia, J. Foster, E. Foster, M. Turakhia et al., Knowledge and attitudes of primary care physicians in the management of patients at risk for cardiovascular events, BMC Family Practice, vol.282, issue.1, p.42, 2008.
DOI : 10.1001/jama.282.15.1458

E. Ford, U. Ajani, J. Croft, J. Critchley, D. Labarthe et al., Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980???2000, New England Journal of Medicine, vol.356, issue.23, pp.2388-2398, 1980.
DOI : 10.1056/NEJMsa053935

J. Brunzell, M. Davidson, C. Furberg, R. Goldberg, B. Howard et al., Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation, Diabetes Care, vol.31, issue.4, pp.811-822, 2008.
DOI : 10.2337/dc08-9018

A. Gotto, . Jr, E. Whitney, E. Stein, D. Shapiro et al., Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) Circulation, pp.477-484, 2000.

A. Sniderman, C. Furberg, A. Keech, J. Van-lennep-roeters, J. Frohlich et al., Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment, The Lancet, vol.361, issue.9359, pp.777-780, 2003.
DOI : 10.1016/S0140-6736(03)12663-3

J. Casas, T. Shah, A. Hingorani, J. Danesh, and M. Pepys, C-reactive protein and coronary heart disease: a critical review, Journal of Internal Medicine, vol.7, issue.4, pp.295-314, 2008.
DOI : 10.1111/j.1365-2796.2008.02015.x

P. Ridker, E. Danielson, F. Fonseca, J. Genest, A. Gotto et al., Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein, New England Journal of Medicine, vol.359, issue.21, pp.2195-2207, 2008.
DOI : 10.1056/NEJMoa0807646

D. Waters, C. Brotons, C. Chiang, J. Ferrières, J. Foody et al., Lipid Treatment Assessment Project 2: A Multinational Survey to Evaluate the Proportion of Patients Achieving Low-Density Lipoprotein Cholesterol Goals, Circulation, vol.120, issue.1, pp.28-34, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.838466

J. Hippisley-cox, C. Coupland, Y. Vinogradova, J. Robson, R. Minhas et al., Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2, BMJ, vol.336, issue.7659, pp.1475-1482, 2008.
DOI : 10.1136/bmj.39609.449676.25

. Artalejo, Rationale and methods of the European Study on Cardiovascular Risk Prevention and Management in Daily Practice (EURIKA) BMC Public Health, p.382, 2010.